TapewireFind a company

person · Reporting owner

PECK KRISTIN C

Disclosed activity across 4 companies

Tapewire entity
14447
SEC CIK
0001488267

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BlackRock Inc.BLK · Entity 12961DirectorJune 28, 2024July 02, 2024
BlackRock, Inc.BLK · Entity 2850DirectorSeptember 30, 2026October 02, 2026
Zoetis Inc.ZTS · Entity 679Director · Chief Executive OfficerOctober 09, 2026October 14, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BlackRock Inc.

Report date June 28, 2024 · Filed July 02, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Shares Of Common Stock (par Value $0.01 Per Share)SEC Table I · non-derivativeDirect1,360 Reported balance After 2024-06-28 transaction · row 1
1 source row

Row 1 · 2024-06-28 · Grant · Acquired 40 · Balance 1,360

F1: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $787.32 per share which was the closing price of the stock on June 28, 2024.

Filing footnotes · ownership attribution and instrument terms

F1: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $787.32 per share which was the closing price of the stock on June 28, 2024.

BlackRock, Inc.

Report date September 30, 2026 · Filed October 02, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Shares Of Common Stock (par Value $0.01 Per Share)SEC Table I · non-derivativeDirect2,092 Reported balance After 2026-09-30 transaction · row 1
1 source row

Row 1 · 2026-09-30 · Grant · Acquired 30 · Balance 2,092

F1: Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $1,058.29 per share which was the closing price of the stock on September 30, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $1,058.29 per share which was the closing price of the stock on September 30, 2026.

Zoetis Inc.

Report date October 09, 2026 · Filed October 14, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom Stock UnitSEC Table II · derivative / convertible securityDirect66,915.04 Reported balance After 2026-10-09 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-10-09 · Grant · Acquired 720.1441 · Balance 66,915.04

F1: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

Filing footnotes · ownership attribution and instrument terms

F1: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

PFIZER INC

Report date October 31, 2012 · Filed November 01, 2012

Section 16 reporting ended · disclosed 2012-11-01. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom Stock Units SSPSEC Table II · derivative / convertible securityDirect6,375 Reported balance After 2012-10-31 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2012-10-31 · Grant · Acquired 39 · Balance 6,375

F1: Each unit represents one phantom share of common stock.

F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Filing footnotes · ownership attribution and instrument terms

F1: Each unit represents one phantom share of common stock.

F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 11, 2023 Filed Feb 14, 2023 21:56 UTC Zoetis Inc. ZTS · Entity 679 Tax withholdingCommon Stock 5,663 $158.33 $896,622.79
Disclosure

SEC source: 0001555280-23-000102 · wf-form4_167641174941492.xml · nonDerivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,490

Read SEC document
February 11, 2023 Filed Feb 14, 2023 21:56 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionCommon Stock 13,410 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-23-000102 · wf-form4_167641174941492.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,153

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
February 08, 2023 Filed Feb 10, 2023 23:30 UTC Zoetis Inc. ZTS · Entity 679 GrantStock Option · Derivative 67,148 $0.00 Strike: $162.07 $0.00
Disclosure

SEC source: 0001555280-23-000064 · wf-form4_167607181592556.xml · derivative · entry 4

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,148

Underlying: Common Stock · 67,148 shares

Expires not disclosed

F11 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.

F12 · derivative.exercise_date: One-third of each option will vest on the first, second and third anniversaries of the date of grant.

F13 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

Read SEC document
February 08, 2023 Filed Feb 10, 2023 23:30 UTC Zoetis Inc. ZTS · Entity 679 GrantRestricted Stock Unit · Derivative 18,047 $0.00 $0.00
Disclosure

SEC source: 0001555280-23-000064 · wf-form4_167607181592556.xml · derivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,047

Underlying: Common Stock · 18,047 shares

Expires not disclosed

F5 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). One-third of the RSUs vest and are settled in shares of Zoetis common stock on each of the first, second and third anniversaries of the date of grant, respectively, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F7 · derivative.exercise_date: One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 08, 2023 Filed Feb 10, 2023 23:30 UTC Zoetis Inc. ZTS · Entity 679 GrantPerformance Award Unit · Derivative 16,574.4404 $0.00 $0.00
Disclosure

SEC source: 0001555280-23-000064 · wf-form4_167607181592556.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,574.4404

Underlying: Common Stock · 16,574.4404 shares

Expires not disclosed

F1 · security: Represents performance award units with a three-year performance period covering 2020-2022 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2023, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 11, 2023, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 11, 2023 subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
January 17, 2023 Filed Jan 20, 2023 00:50 UTC BlackRock Inc. BLK · Entity 12961 GrantShares Of Common Stock (par Value $0.01 Per Share) 323 $743.61 $240,186.03
Disclosure

SEC source: 0001127602-23-001877 · form4.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 830

F1 · shares: Restricted Stock Units granted to non-employee directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $743.61 per share which was the average of the high and low price per share of Common Stock on January 17, 2023. Restricted Stock Units vest upon the director's election or re-election, as applicable, at the 2023 Annual Meeting of Shareholders and will be settled in shares of Common Stock on the third anniversary of the date of grant, unless the director has elected to receive settlement of such shares on the date that he or she ceases to be a member of the Board (either in a lump sum or in five equal annual installments beginning on such date).

Read SEC document
January 13, 2023 Filed Jan 18, 2023 21:30 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 271.3876 $51.02 $13,846.20
Disclosure

SEC source: 0001555280-23-000017 · wf-form4_167407739516231.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,482.4497

Underlying: Common Stock · 13,786.1956 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
December 30, 2022 Filed Jan 4, 2023 23:10 UTC BlackRock Inc. BLK · Entity 12961 GrantShares Of Common Stock (par Value $0.01 Per Share) 39 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-000673 · form4.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 507

F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $708.63 per share which was the closing price of the stock on December 30, 2022.

Read SEC document
October 07, 2022 Filed Oct 11, 2022 20:37 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 345.4641 $46.76 $16,153.90
Disclosure

SEC source: 0001555280-22-000253 · wf-form4_166552061255255.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,211.0621

Underlying: Common Stock · 13,710.7232 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
September 30, 2022 Filed Oct 4, 2022 23:29 UTC BlackRock Inc. BLK · Entity 12961 GrantShares Of Common Stock (par Value $0.01 Per Share) 50 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-023597 · form4.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 468

F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $550.28 per share which was the closing price of the stock on September 30, 2022.

Read SEC document
July 21, 2022 Filed Jul 25, 2022 20:08 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionStock Option · Derivative 4,964 $0.00 $0.00
Disclosure

SEC source: 0001555280-22-000217 · wf-form4_165877971671145.xml · derivative · entry 5

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 322,014

Underlying: Common Stock · 4,964 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.

F8 · derivative.exercise_price: 4,964 options granted February 19, 2016 at an exercise price of $41.83 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F9 · balance_after: 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,250 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option.

Read SEC document
July 21, 2022 Filed Jul 25, 2022 20:08 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionStock Option · Derivative 4,725 $0.00 $0.00
Disclosure

SEC source: 0001555280-22-000217 · wf-form4_165877971671145.xml · derivative · entry 4

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 326,978

Underlying: Common Stock · 4,725 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.

F4 · derivative.exercise_price: 4,725 options granted March 4, 2014 at an exercise price of $30.89 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option.

Read SEC document
July 21, 2022 Filed Jul 25, 2022 20:08 UTC Zoetis Inc. ZTS · Entity 679 SaleCommon Stock 9,689 $180.00 $1,744,020.00
Disclosure

SEC source: 0001555280-22-000217 · wf-form4_165877971671145.xml · nonDerivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,743

F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.

Read SEC document
July 21, 2022 Filed Jul 25, 2022 20:08 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionCommon Stock 4,964 $41.83 $207,644.12
Disclosure

SEC source: 0001555280-22-000217 · wf-form4_165877971671145.xml · nonDerivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,432

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 21, 2022 Filed Jul 25, 2022 20:08 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionCommon Stock 4,725 $30.89 $145,955.25
Disclosure

SEC source: 0001555280-22-000217 · wf-form4_165877971671145.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,468

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2021.

Read SEC document
July 15, 2022 Filed Jul 19, 2022 21:15 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 294.8868 $54.78 $16,153.90
Disclosure

SEC source: 0001555280-22-000210 · wf-form4_165826530638013.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,865.598

Underlying: Common Stock · 13,453.5204 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
July 07, 2022 Filed Jul 11, 2022 20:08 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionStock Option · Derivative 311 $0.00 $0.00
Disclosure

SEC source: 0001555280-22-000195 · wf-form4_165757010092779.xml · derivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 331,703

Underlying: Common Stock · 311 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.

F3 · derivative.exercise_price: 311 options granted March 4, 2014 at an exercise price of $30.89 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 4,725 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option.

Read SEC document
July 07, 2022 Filed Jul 11, 2022 20:08 UTC Zoetis Inc. ZTS · Entity 679 SaleCommon Stock 311 $180.00 $55,980.00
Disclosure

SEC source: 0001555280-22-000195 · wf-form4_165757010092779.xml · nonDerivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,743

Read SEC document
July 07, 2022 Filed Jul 11, 2022 20:08 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionCommon Stock 311 $30.89 $9,606.79
Disclosure

SEC source: 0001555280-22-000195 · wf-form4_165757010092779.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,054

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2021.

Read SEC document
June 30, 2022 Filed Jul 1, 2022 20:48 UTC BlackRock Inc. BLK · Entity 12961 GrantShares Of Common Stock (par Value $0.01 Per Share) 45 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-018531 · form4.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 418

F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $609.04 per share which was the closing price of the stock on June 30, 2022.

Read SEC document
April 08, 2022 Filed Apr 13, 2022 00:10 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 1,858.4593 $62.20 $115,596.17
Disclosure

SEC source: 0001555280-22-000161 · wf-form4_164980860463552.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,570.7112

Underlying: Common Stock · 13,233.5361 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
March 31, 2022 Filed Apr 4, 2022 22:53 UTC BlackRock Inc. BLK · Entity 12961 GrantShares Of Common Stock (par Value $0.01 Per Share) 33 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-011343 · form4.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 373

F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $764.17 per share which was the closing price of the stock on March 31, 2022.

Read SEC document
March 30, 2022 Filed Apr 1, 2022 22:09 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 2,658.1616 $59.61 $158,453.01
Disclosure

SEC source: 0001555280-22-000142 · wf-form4_164885096055013.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,712.2519

Underlying: Common Stock · 828.2093 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
February 25, 2022 Filed Feb 28, 2022 21:58 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionStock Option · Derivative 10,000 $0.00 $0.00
Disclosure

SEC source: 0001555280-22-000116 · wf-form4_164608546701011.xml · derivative · entry 4

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,014

Underlying: Common Stock · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.

F5 · derivative.exercise_price: 10,000 options granted March 4, 2014 at an exercise price of $30.89 per option.

F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F8 · balance_after: 5,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option.

Read SEC document
February 25, 2022 Filed Feb 28, 2022 21:58 UTC Zoetis Inc. ZTS · Entity 679 SaleCommon Stock 5,600 $192.59 $1,078,504.00
Disclosure

SEC source: 0001555280-22-000116 · wf-form4_164608546701011.xml · nonDerivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,743

F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.32 to $192.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 25, 2022 Filed Feb 28, 2022 21:58 UTC Zoetis Inc. ZTS · Entity 679 SaleCommon Stock 4,400 $191.91 $844,404.00
Disclosure

SEC source: 0001555280-22-000116 · wf-form4_164608546701011.xml · nonDerivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,343

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.28 to $192.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 25, 2022 Filed Feb 28, 2022 21:58 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionCommon Stock 10,000 $30.89 $308,900.00
Disclosure

SEC source: 0001555280-22-000116 · wf-form4_164608546701011.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,743

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2021.

Read SEC document
February 12, 2022 Filed Feb 16, 2022 00:57 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionPerformance Award Unit · Derivative 18,036.4652 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-22-000105 · wf-form4_164497305189110.xml · derivative · entry 6

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,036.4652 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock.

F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock.

F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2019-2021 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 12, 2022 and were settled in shares of Zoetis common stock.

Read SEC document
February 12, 2022 Filed Feb 16, 2022 00:57 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionRestricted Stock Unit · Derivative 5,230.2901 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-22-000105 · wf-form4_164497305189110.xml · derivative · entry 5

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,673.0351

Underlying: Common Stock · 5,230.2901 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 5,230.2901 RSUs vested on February 12, 2022; 13,303.8173 RSUs will vest on February 11, 2023; 14,460.2178 RSUs will vest on February 10, 2024; and 13,909 RSUs will vest on February 8, 2025.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 5,230.2901 RSUs vested on February 12, 2022; 13,303.8173 RSUs will vest on February 11, 2023; 14,460.2178 RSUs will vest on February 10, 2024; and 13,909 RSUs will vest on February 8, 2025.

F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 5,230.2901 RSUs vested on February 12, 2022; 13,303.8173 RSUs will vest on February 11, 2023; 14,460.2178 RSUs will vest on February 10, 2024; and 13,909 RSUs will vest on February 8, 2025.

Read SEC document
February 12, 2022 Filed Feb 16, 2022 00:57 UTC Zoetis Inc. ZTS · Entity 679 Tax withholdingCommon Stock 8,127 $198.87 $1,616,216.49
Disclosure

SEC source: 0001555280-22-000105 · wf-form4_164497305189110.xml · nonDerivative · entry 4

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,743

Read SEC document
February 12, 2022 Filed Feb 16, 2022 00:57 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionCommon Stock 18,036 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-22-000105 · wf-form4_164497305189110.xml · nonDerivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,870

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

Read SEC document
February 12, 2022 Filed Feb 16, 2022 00:57 UTC Zoetis Inc. ZTS · Entity 679 Tax withholdingCommon Stock 1,820 $198.87 $361,943.40
Disclosure

SEC source: 0001555280-22-000105 · wf-form4_164497305189110.xml · nonDerivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,834

Read SEC document
February 12, 2022 Filed Feb 16, 2022 00:57 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionCommon Stock 5,230 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-22-000105 · wf-form4_164497305189110.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,654

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
February 08, 2022 Filed Feb 10, 2022 23:41 UTC Zoetis Inc. ZTS · Entity 679 GrantStock Option · Derivative 54,751 $0.00 $0.00
Disclosure

SEC source: 0001555280-22-000063 · wf-form4_164453644692465.xml · derivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 342,014

Underlying: Common Stock · 54,751 shares

Expires not disclosed

F9 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F10 · derivative.exercise_price: 15,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option.

F11 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F12 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F10 · balance_after: 15,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option.

Read SEC document
February 08, 2022 Filed Feb 10, 2022 23:41 UTC Zoetis Inc. ZTS · Entity 679 GrantRestricted Stock Unit · Derivative 13,909 $0.00 $0.00
Disclosure

SEC source: 0001555280-22-000063 · wf-form4_164453644692465.xml · derivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,903.3252

Underlying: Common Stock · 13,909 shares

Expires not disclosed

F5 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F7 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F8 · balance_after: The RSUs vest as follows: 5,230.2901 RSUs will vest on February 12, 2022; 13,303.8173 RSUs will vest on February 11, 2023; 14,460.2178 RSUs will vest on February 10, 2024; and 13,909 RSUs will vest on February 8, 2025.

Read SEC document
February 08, 2022 Filed Feb 10, 2022 23:41 UTC Zoetis Inc. ZTS · Entity 679 GrantPerformance Award Unit · Derivative 18,036.4652 $0.00 $0.00
Disclosure

SEC source: 0001555280-22-000063 · wf-form4_164453644692465.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,036.4652

Underlying: Common Stock · 18,036.4652 shares

Expires not disclosed

F1 · security: Represents performance award units with a three-year performance period covering 2019-2021 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
January 18, 2022 Filed Jan 20, 2022 23:26 UTC BlackRock Inc. BLK · Entity 12961 GrantShares Of Common Stock (par Value $0.01 Per Share) 288 $832.07 $239,636.16
Disclosure

SEC source: 0001127602-22-001770 · form4.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340

F1 · shares: Restricted Stock Units granted to non-employee directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $832.07 per share which was the average of the high and low price per share of Common Stock on January 18, 2022. Restricted Stock Units vest upon the director's election or re-election, as applicable, at the 2022 Annual Meeting of Shareholders and will be settled in shares of Common Stock on the third anniversary of the date of grant, unless the director has elected to receive settlement of such shares on the date that he or she ceases to be a member of the Board (either in a lump sum or in five equal annual installments beginning on such date).

Read SEC document
January 14, 2022 Filed Jan 19, 2022 22:12 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 216.7872 $63.87 $13,846.20
Disclosure

SEC source: 0001555280-22-000023 · wf-form4_164263030833228.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,054.0903

Underlying: Common Stock · 67.1559 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 23:01 UTC BlackRock Inc. BLK · Entity 12961 GrantShares Of Common Stock (par Value $0.01 Per Share) 27 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-000651 · form4.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52

F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $915.56 per share which was the closing price of the stock on December 31, 2021.

Read SEC document
November 26, 2021 Filed Nov 29, 2021 21:46 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionStock Option · Derivative 12,000 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000344 · wf-form4_163822238794400.xml · derivative · entry 7

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 287,263

Underlying: Common Stock · 12,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 12,000 options granted March 4, 2014 at an exercise price of $30.89 per option.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F10 · balance_after: 15,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; and 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option.

Read SEC document
November 26, 2021 Filed Nov 29, 2021 21:46 UTC Zoetis Inc. ZTS · Entity 679 SaleCommon Stock 200 $225.44 $45,088.00
Disclosure

SEC source: 0001555280-21-000344 · wf-form4_163822238794400.xml · nonDerivative · entry 6

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,424

Read SEC document
November 26, 2021 Filed Nov 29, 2021 21:46 UTC Zoetis Inc. ZTS · Entity 679 SaleCommon Stock 2,200 $224.72 $494,384.00
Disclosure

SEC source: 0001555280-21-000344 · wf-form4_163822238794400.xml · nonDerivative · entry 5

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,624

F5 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.36 to $225.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 26, 2021 Filed Nov 29, 2021 21:46 UTC Zoetis Inc. ZTS · Entity 679 SaleCommon Stock 3,600 $223.78 $805,608.00
Disclosure

SEC source: 0001555280-21-000344 · wf-form4_163822238794400.xml · nonDerivative · entry 4

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,824

F4 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.27 to $224.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 26, 2021 Filed Nov 29, 2021 21:46 UTC Zoetis Inc. ZTS · Entity 679 SaleCommon Stock 7,900 $222.37 $1,756,723.00
Disclosure

SEC source: 0001555280-21-000344 · wf-form4_163822238794400.xml · nonDerivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,424

F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.27 to $223.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 26, 2021 Filed Nov 29, 2021 21:46 UTC Zoetis Inc. ZTS · Entity 679 SaleCommon Stock 600 $221.92 $133,152.00
Disclosure

SEC source: 0001555280-21-000344 · wf-form4_163822238794400.xml · nonDerivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,324

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.26 to $222.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 26, 2021 Filed Nov 29, 2021 21:46 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionCommon Stock 12,000 $30.89 $370,680.00
Disclosure

SEC source: 0001555280-21-000344 · wf-form4_163822238794400.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2020.

Read SEC document
October 08, 2021 Filed Oct 12, 2021 20:23 UTC Zoetis Inc. ZTS · Entity 679 GrantPhantom Stock Unit · Derivative 263.3502 $61.34 $16,153.90
Disclosure

SEC source: 0001555280-21-000319 · wf-form4_163407018483793.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,837.3029

Underlying: Common Stock · 81.6348 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 22:15 UTC BlackRock Inc. BLK · Entity 12961 GrantShares Of Common Stock (par Value $0.01 Per Share) 25 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-026516 · form4.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25

F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $838.66 per share which was the closing price of the stock on September 30, 2021.

Read SEC document
August 25, 2021 Filed Aug 26, 2021 21:08 UTC Zoetis Inc. ZTS · Entity 679 Exercise / conversionStock Option · Derivative 12,000 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000295 · wf-form4_163001209828688.xml · derivative · entry 4

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 299,263

Underlying: Common Stock · 12,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F5 · derivative.exercise_price: 12,000 options granted March 4, 2014 at an exercise price of $30.89 per option.

F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F8 · balance_after: 27,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; and 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option.

Read SEC document
August 25, 2021 Filed Aug 26, 2021 21:08 UTC Zoetis Inc. ZTS · Entity 679 SaleCommon Stock 2,506 $204.32 $512,025.92
Disclosure

SEC source: 0001555280-21-000295 · wf-form4_163001209828688.xml · nonDerivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,924

F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.02 to $204.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.